Epirubicin, Cisplatin, and Prolonged or Brief Infusional 5-Fluorouracil in the Treatment of Carcinoma of Unknown Primary Site

Author： Karapetis C.S.   Yip D.   Virik K.   Strickland A.   Ryder K.   Cowling M.   Harper P.G.  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.18, Iss.1, 2001-03, pp. : 23-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site

By  

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 259-264

Humana Press, Inc

Access to resources Recommend Favorite

Epirubicin, Cisplatin and Infusional 5-Fluorouracil (5-FU) (ECF) in Hepatobiliary Tumours

By Ellis P.A.   Norman A.   Hill A.   O'Brien M.E.R.   Nicolson M.   Hickish T.   Cunningham D.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1594-1598

Elsevier

Access to resources Recommend Favorite

Gemcitabine and cisplatin in patients with carcinoma of unknown primary site

By Isik Metin  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 591-596

Humana Press, Inc

Access to resources Recommend Favorite

Non-infusional 5-Fluorouracil, Doxorubicin and Cisplatin in the Treatment of Locally Advanced or Metastatic Gastro-oesophageal Adenocarcinoma

By Pentheroudakis George   Lim K. Chee   Dunlop David J.   Soukop Mike   Eatock Martin M.  

Acta Oncologica, Vol. 40, Iss. 7, 2001-11 ,pp. : 855-861

Informa Healthcare

Access to resources Recommend Favorite

Primary Radiation, Cisplatin, and 5-Fluorouracil for Advanced Squamous Carcinoma of the Vulva

By Cunningham M.J.   Goyer R.P.   Gibbons S.K.   Kredentser D.C.   Malfetano J.H.   Keys H.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 258-261

Elsevier

Access to resources Recommend Favorite